Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer Matched-pair analysis

Strahlentherapie und Onkologie

Volumn 188, Issue 10, 2012, Pages 917-925

  Pinkawa, M ^a   Piroth, M D ^a   Holy, R ^a   Escobar Corral, N ^a   Caffaro, M ^a   Djukic, V ^a   Klotz, J ^a   Eble, M J ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Conformal radiotherapy; Intensity modulated radiotherapy; Prostate neoplasm; Quality of life; Spacer gel; Toxicity

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CASE CONTROL STUDY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION URGENCY; DIARRHEA; EXPANDED PROSTATE CANCER INDEX COMPOSITE; FECES INCONTINENCE; HEMATOCHEZIA; HUMAN; HYDROGEL; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; PAIN; PROSTATE CARCINOMA; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RADIATION INJURY; RADIATION PROTECTION; SELF REPORT;

ADULT; AGED; ERECTILE DYSFUNCTION; HUMANS; HYDROGEL; HYDROGELS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; PROSTHESIS DESIGN; QUALITY OF LIFE; RADIATION PROTECTION; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME; URINARY INCONTINENCE;

EID: 84866685265     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0172-6     Document Type: Article

References (34)

1. Akimoto T, Muramatsu H, Takahashi M et al (2004) Rectal bleeding after hypofractionated radiotherapy for prostate cancer: correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding. Int J Radiat Oncol Biol Phys 60:1033-1039
2. Al-Mamgani A, Putten WL van, Heemsbergen WD et al (2008) Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 72:980-988
3. Bohrer M, Schröder P, Welzel G et al (2008) Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT™ (b-mode acquisition and targeting) for prostate cancer. Strahlenther Onkol 184:674-678
4. Brenner DJ (2004) Fractionation and late rectal toxicity. Int J Radiat Oncol Biol Phys 60:1013-1015
5. Dearnaley D, Syndikus I, Sumo G et al (2012) Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trials. Lancet Oncol 13:43-54
6. Ferlay J, Parkin DM, Steliarova-Foucher E (2008) Estimates of cancer incidence and mortality in Europe 2008. Eur J Cancer 46:765-781
7. Fiorino C, Sanguineti G, Cozzarini C et al (2003) Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 57:953-962
8. Geier M, Astner ST, Duma MN et al (2012) Dose-escalated simultaneous integrated-boost treatment of prostate cancer patients via helical tomotherapy. Strahlenther Onkol (in press)
9. Goldner G, Potter R, Battermann JJ et al (2012) Comparison of seed brachytherapy or external beam radiotherapy (70 Gy or 74 Gy) in 919 low-risk prostate cancer patients. Strahlenther Onkol 188:305-310
10. Goldner G, Sljivic S, Oismueller R et al (2011) Prostate cancer radiotherapy in Austria: overview on number of patients, intention to treat, and treatment techniques based on data from 2007. Strahlenther Onkol 187:279-283
11. Goldner G, Tomicek B, Becker G et al (2007) Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients. Int J Radiat Oncol Biol Phys 67:78-83
12. Hatiboglu G, Pinkawa M, Vallée J et al (2012) Application technique: placement of a prostate-rectum spacer in men undergoing prostate radiation therapy. BJU Int (in press)
13. Heidenreich A, Bellmunt J, Bolla M et al (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59:61-71
14. ICRU (1993) ICRU report 50: prescribing, recording and reporting photon beam therapy. International Commission on Radiation Units and Measurements
15. Kupelian PA, Potters L, Khuntia D et al (2004) Radical prostatectomy, external beam radiotherapy 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 58:25-33
16. Michalski JM, Winter K, Purdy JA et al (2005) Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. Int J Radiat Oncol Biol Phys 62:706-713
17. Moman MR, Heide UA van der, Kotte AN et al (2010) Long-term experience with transrectal and transperineal implantations of fiducial gold markers in the prostate for position verification in external beam radiotherapy; feasibility, toxicity and quality of life. Radiother Oncol 96:38-42
18. Osoba D, Rodrigues G, Myles J et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16:139-144
19. Peinemann F, Grouven U, Bartel C et al (2011) Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: a systematic review of randomised and nonrandomised controlled clinical trials. Eur Urol 60:881-893
20. Pinkawa M, Corral NE, Caffaro M et al (2011) Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer. Radiother Oncol 100:436-441
21. Pinkawa M, Holy R, Piroth MD et al (2010) Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study. Radiat Oncol 5:27
22. Pinkawa M, Holy R, Piroth MD et al (2011) Interpreting the clinical significance of quality of life score changes after radiotherapy for localized prostate cancer. Curr Urol 5:137-144
23. Pinkawa M, Piroth MD, Holy R et al (2011) Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer. Strahlenther Onkol 187:479-484
24. Pinkawa M, Asadpour B, Gagel B et al (2006) Prostate position variability and dose-volume histograms in radiotherapy for prostate cancer with full and empty bladder. Int J Radiat Oncol Biol Phys 64:856-861
25. Pinkawa M, Pursch-Lee M, Asadpour B et al (2008) Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate localization for the analysis of inter- and intrafraction organ motion. Strahlenther Onkol 184:679-685
26. Potters L, Klein EA, Kattan MW et al (2004) Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 71:29-33
27. Prada PJ, Fernandez J, Martinez AA et al (2007) Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients. Int J Radiat Oncol Biol Phys 69:95-102
28. Prada PJ, Gonzalez H, Menendez C et al (2009) Transperineal injection of hyaluronic acid in the anterior perirectal fat to decrease rectal toxicity from radiation delivered with low-dose-rate brachytherapy for prostate cancer patients. Brachytherapy 8:210-217
29. Schulze D, Liang J, Yan D et al (2009) Comparison of various online IGRT strategies: The benefits of online treatment plan re-optimization. Radiother Oncol 90:367-376
30. Viani GA, Stefano EJ, Alfonso SL (2009) Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials. Int J Radiat Oncol Biol Phys 74:1405-1418
31. Volz-Sidiropoulou E, Pinkawa M, Fischedick K et al (2008) Factor analysis of the Expanded Prostate Cancer Index Composite (EPIC) in a patient group after primary (external beam radiotherapy and permanent iodine-125 brachytherapy) and postoperative radiotherapy for prostate cancer. Curr Urol 2:122-129
32. Wei JT, Dunn RL, Litwin MS et al (2000) Development and validation of the expanded prostate cancer index composite (epic) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56:899-905
33. Yaparpalvi R, Hong L, Mah D et al (2009) ICRU reference dose in an era of intensity-modulated radiation therapy clinical trials: correlation with planning target volume mean dose and suitability for intensity-modulated radiation therapy dose prescription. Radiother Oncol 89:347-352
34. Zucca S, Carau B, Solla I et al (2011) Prostate image-guided radiotherapy by megavolt cone-beam CT. Strahlenther Onkol 187:473-478